The result displayed that majority of the negative immune regulatory genes glioma were upregulated in the high-risk group (Figure 6(a)), and the expression of immune checkpoint CTLA4 and immune checkpoint receptor LAG3 was notably higher in the high-risk group (Figures 6(b) and 6(c)). The gene discussed is LAG3; the disease is glioma.